About MitoconBiopharma
MitoconBiopharma is a Healthcare company based in Hyderabad (India) founded in 2019. It offers pharmacovigilance, regulatory affairs, clinical monitoring, and safety services to worldwide clients. It operates on a B2B model. The company has 84 employees. Its Indian entity Mitocon Biopharma Private Limited reported revenue of ₹6.40 Cr. MitoconBiopharma offers products and services including Medical Device Vigilance, Strategic Regulatory Affairs, Product Safety & Pharmacovigilance, Clinical Monitoring Services, and Quality Compliance Matrix. Its focus areas include Pharmacovigilance, Drug Safety, Case Management and Regulatory Affairs. Its competitors include Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group and 2 more; 3 of its 7 listed competitors have raised funding.
Company details
Mitocon Biopharma is a contract research organization specializing in biopharmaceutical services that transform scientific discoveries into treatments through data capture and analysis. They provide pharmacovigilance, regulatory affairs, clinical monitoring, and quality compliance to pharmaceutical, biotech, and medical device industries. Based in Hyderabad, India, they ensure data security and timely delivery with experienced professionals. Their focus includes global client support and compliance management.
- Headquarters Hyderabad, India
- Employees 84
- SectorsHealthcare
- Email••••••••
- Website mitoconbiopharma.com
- Legal Name Mitocon Biopharma Private Limited
- Date of Incorporation 07 Feb, 2019
- Jurisdiction Secunderabad, Telangana, India
- Annual Revenue₹6.40 Cr
FY 2023 · +81% YoY
- Net Profit₹50.3 Lakh
FY 2023 · 8% margin
- EBITDA₹61.2 Lakh
FY 2023 · 10% margin
- Employee Count84
Associated legal entities of MitoconBiopharma
MitoconBiopharma operates through Mitocon Biopharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mitocon Biopharma Private Limited CIN U24299TG2019PTC130358 | Active | 07 Feb 2019 | Secunderabad, Telangana | ₹6.4 Cr | 84 | 2 | View details |
Products & Services of MitoconBiopharma
MitoconBiopharma offers a comprehensive portfolio of products and services, including Medical Device Vigilance, Strategic Regulatory Affairs, Product Safety & Pharmacovigilance, Clinical Monitoring Services, and Quality Compliance Matrix.
Manages safety data and incident processing for medical devices.
Assists in dossier development and regulatory submissions for compliance.
Handles case management and reporting for adverse drug effects.
Delivers monitoring and data analysis for clinical trials.
Evaluates and ensures regulatory compliance for business processes.
Board of directors of Mitocon Biopharma Private Limited (MitoconBiopharma)
Mitocon Biopharma Private Limited is the primary company behind MitoconBiopharma. The board of Mitocon Biopharma Private Limited currently have 2 directors; the longest-serving is Pabba Ragha Veni, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pabba Ragha Veni DIN 08354510 | Director | 07 Feb 2019 | 7 yrs 8 mo | Mitocon Biopharma Private Limited |
| Garlapati Ramulu DIN 08354511 | Director | 07 Feb 2019 | 7 yrs 8 mo | Mitocon Biopharma Private Limited |
Financials of MitoconBiopharma
Figures of Mitocon Biopharma Private Limited, the primary company behind MitoconBiopharma, for FY 2023. Revenue was ₹6.40 Cr (+81% year on year). Net profit was ₹50.3 Lakh (8% margin). EBITDA was ₹61.2 Lakh (10% margin). Revenue has grown at a compounded annual rate of +57% over three years.
- ₹6.40 CrRevenue · FY 2023 · +81% YoY
- ₹50.3 LakhNet profit · 8% margin
- ₹61.2 LakhEBITDA · 10% margin
- ₹1 LakhPaid-up capital
- 84Employees (provident fund records)
- +57%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Mitocon Biopharma Private Limited are on its company page.
Detailed financial statements for MitoconBiopharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of MitoconBiopharma
MitoconBiopharma has 7 listed competitors in our database, 3 of them funded. They include Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indegene.com | 1998 | Princeton, United States | $220M | 350 | Suite solutions are provided for payers and healthcare providers. | |
| zuelligpharma.com | 1992 | Singapore | – | – | Healthcare access in Asia is enhanced by Zuellig Pharma. | |
| integrichain.com | 2005 | Philadelphia, United States | $2M | 320 | Inventory, order and customer relationship management solution for life science suppliers. | |
| clinigengroup.com | 2010 | Burton-on-trent, United Kingdom | – | – | Specialty medicines are supplied via clinical trials and access programs. | |
| sciencegroup.com | 1995 | Cambridge, United Kingdom | – | 431 | Technology-based consultancy and product development services are provided. | |
| clearviewhcp.com | 2008 | Newton, United States | – | 381 | Strategic consulting services are provided to life sciences companies. | |
| fabtechnologies.com | 2002 | Mumbai, India | $175,048 | 279 | Instruments for biotech, pharmaceutical, and biomedical sectors are manufactured. |
Detailed competitors of MitoconBiopharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as MitoconBiopharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MitoconBiopharma
MitoconBiopharma was founded in 2019.
MitoconBiopharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
MitoconBiopharma has 84 employees.
The primary company behind MitoconBiopharma, Mitocon Biopharma Private Limited, reported revenue of ₹6.40 Cr for FY 2023, up 81% year on year.
Mitocon Biopharma is a contract research organization specializing in biopharmaceutical services that transform scientific discoveries into treatments through data capture and analysis. They provide pharmacovigilance, regulatory affairs, clinical monitoring, and quality compliance to pharmaceutical, biotech, and medical device industries. Based in Hyderabad, India, they ensure data security and timely delivery with experienced professionals. Their focus includes global client support and compliance management.
MitoconBiopharma's top competitors include Indegene, Zuellig Pharma and IntegriChain.
MitoconBiopharma offers Medical Device Vigilance, Strategic Regulatory Affairs, Product Safety & Pharmacovigilance, Clinical Monitoring Services, and Quality Compliance Matrix.
MitoconBiopharma operates through Mitocon Biopharma Private Limited.
The legal entities of MitoconBiopharma currently have 2 directors, including Pabba Ragha Veni, Garlapati Ramulu.